Sign In
Buy LLY
$1,185.71
-7.09 (-0.594%)
At Close: Aug 07, 2026
10 Imploding Stocks Cost Investors A Staggering $2 Trillion
08:00am, Monday, 05'th Aug 2024
The S&P 500 is down "only" 6.1% since its July 16 high. So why does the drop feel so bad?
Lilly, Novo Nordisk battle for weight-loss market lands at the pharmacy shelf
06:06am, Monday, 05'th Aug 2024
As Eli Lilly's weight-loss drug Zepbound gains ground in the U.S. against Novo Nordisk's Wegovy, some doctors say their guiding principle for writing prescriptions is simple: which drug can my patient
Should You Buy Eli Lilly Before Aug. 8?
05:10am, Monday, 05'th Aug 2024
Eli Lilly shares have soared more than 230% over the past three years. The company has generated major growth thanks to its weight loss drugs.
NEW YORK, NY / ACCESSWIRE / August 4, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Morphic Holding, Inc. ("Morphic") (NASDAQ:MORF) and Eli Lilly and Company ("Eli Lill
Eli Lilly: I Expect Strong Q2 Earnings, But The Valuation Is Already Optimistic
09:00am, Sunday, 04'th Aug 2024
My initial bearish thesis about Eli Lilly stock did not age well, as the stock has performed well since February despite being substantially overvalued. However, the market appears to be comfortable w
Eli Lilly's Obesity Drug Shows a Heart Benefit. Is It Time to Buy?
05:26am, Sunday, 04'th Aug 2024
A clinical trial starring patients with both obesity and heart failure says treatment with tirzepatide provides a big risk reduction. Tirzepatide is the active ingredient in both Mounjaro, a diabetes
Eli Lilly: Becoming the world's biggest pharmaceutical company 1876-2024
12:00am, Sunday, 04'th Aug 2024
With a rich history dating back to the 19th century, Eli Lilly (LLY) has faced struggles and successes. But a booming market cap has quickly turned it into the biggest pharmaceutical brand in the worl
Eli Lilly vs Novo Nordisk: A Recent Study Suggests This Company Has the Best Weight Loss Drug
06:20am, Saturday, 03'rd Aug 2024
A recent study compared the effectiveness of tirzepatide against semaglutide. Tirzepatide has been more effective in helping people lose weight in trials, and the study corroborated that.
Is This Decision by Pfizer Bad News for Eli Lilly?
04:10am, Saturday, 03'rd Aug 2024
Eli Lilly is a giant in the world of weight loss drugs, generating billions of dollars in revenue. Rival big pharma player Pfizer aims to get in on this major market.
Eli Lilly's Zepbound and Mounjaro now available in U.S. after shortages, FDA says
04:22pm, Friday, 02'nd Aug 2024
All doses of Eli Lilly's highly popular weight loss injection Zepbound and diabetes drug Mounjaro are now available in the U.S., according to an update on the Food and Drug Administration's drug short
Calling All Morphic Holding, Inc. (MORF) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your Losses
04:00pm, Friday, 02'nd Aug 2024
NEW YORK, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Morphic Holding, Inc. (“Morphic”) (NASDAQ: MORF) and Eli
US FDA says all doses of Lilly's weight-loss and diabetes drug now available
02:48pm, Friday, 02'nd Aug 2024
All doses of Eli Lilly's weight-loss drug Zepbound and diabetes drug Mounjaro are now available, the U.S. Food and Drug Administration's updated shortage list showed on Friday.
NEW YORK, NY / ACCESSWIRE / August 2, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Morphic Holding, Inc. ("Morphic") (NASDAQ:MORF) and Eli Lilly and Company ("Eli Lill
Why Eli Lilly Stock Trounced the Market on Thursday
06:35pm, Thursday, 01'st Aug 2024
The pharmaceutical giant's CEO had some very good news to report about a hot product. The medication should come off the FDA's shortage list in the immediate future, according to him.
Health care bucks sell-off as Eli Lilly soars: Mizuho's Jared Holz on what's next for the group
06:19pm, Thursday, 01'st Aug 2024
Jared Holz, Mizuho, joins 'Fast Money' to talk resilience in the health care sector as the broader market sees a sell-off.
